Table 4

 Responder and non-responder frequency with acute L-dopa challenge

Group (n)UPDRS III>20%FT >20%WT >20%RespondersNon-responders
Responder: defined as a group of patient manifesting > 20% improvement in two or more of the three motor tests after introduction of L-dopa therapy. Non-responder: defined as <10% improvement in two or more of the three motor tests. FT, finger tapping; WT, walking test.
DLB (14)5495 (36%)4 (29%)
PDD (30)16202121 (70%)3 (10%)
PD (28)14141416 (57%)6 (21%)